Analysis of Present Status for Surgery of Benign Prostatic Hyperplasia in Korea Using Nationwide Healthcare System Data
0
조회
0
다운로드
9
인용
0
참고문헌
키워드
초록
Purpose: There are no established statistical data available for the comparison of different surgical methods adopted for the resection of benign prostatic hyperplasia (BPH). This study investigates the present status related to BPH surgery in Korea for the past 8 years. Methods: National-level data from the National Health Insurance Service and National Statistical Office were analyzed in this study. From 2010 to 2017, the trends of surgeries for BPH were reviewed according to the procedure code including transurethral resection of the prostate (TURP), holmium laser enucleation of the prostate (HoLEP), or high-power potassium titanyl phosphate (KTP), and this trend also analyzed by age, geographic distribution, and hospital type. Results: Over the past 8 years, there was not much change in the total number of BPH-related surgeries (range, 10,393– 11,072). Although there was not much alteration in the number of conventional TURP (from 6,801 in 2010 to 6,645 in 2017), the number of HoLEP has dramatically increased (from 278 in 2010 to 3,805 in 2017). The number of HoLEP surgeries after 2011 exceeded the number of surgeries using KTP, and the gap is anticipated to rise. The number of surgeries by age group was most common in the 70s and the total number of surgeries is decreasing in all age groups; for HoLEP, the trend is steadily increasing over the age of 60 years. Most of the BPH surgeries were performed in metropolitan areas, such as Seoul, Gyeonggido, and Busan, and in larger hospitals compared to smaller hospital settings. Conclusions: Through the data of the National Health Insurance Service, we could apprehend the present status of BPH-related surgery in Korea. Then, we could know about the trend according to several factors and we think these results will be valuable as academic references as well.
Abstract
Purpose: There are no established statistical data available for the comparison of different surgical methods adopted for the resection of benign prostatic hyperplasia (BPH). This study investigates the present status related to BPH surgery in Korea for the past 8 years. Methods: National-level data from the National Health Insurance Service and National Statistical Office were analyzed in this study. From 2010 to 2017, the trends of surgeries for BPH were reviewed according to the procedure code including transurethral resection of the prostate (TURP), holmium laser enucleation of the prostate (HoLEP), or high-power potassium titanyl phosphate (KTP), and this trend also analyzed by age, geographic distribution, and hospital type. Results: Over the past 8 years, there was not much change in the total number of BPH-related surgeries (range, 10,393– 11,072). Although there was not much alteration in the number of conventional TURP (from 6,801 in 2010 to 6,645 in 2017), the number of HoLEP has dramatically increased (from 278 in 2010 to 3,805 in 2017). The number of HoLEP surgeries after 2011 exceeded the number of surgeries using KTP, and the gap is anticipated to rise. The number of surgeries by age group was most common in the 70s and the total number of surgeries is decreasing in all age groups; for HoLEP, the trend is steadily increasing over the age of 60 years. Most of the BPH surgeries were performed in metropolitan areas, such as Seoul, Gyeonggido, and Busan, and in larger hospitals compared to smaller hospital settings. Conclusions: Through the data of the National Health Insurance Service, we could apprehend the present status of BPH-related surgery in Korea. Then, we could know about the trend according to several factors and we think these results will be valuable as academic references as well.
참고문헌 (23)
- McConnell JD, "The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia", N Engl J Med, 349, pp.2387~2398 (2003)
- "Health Insurance Review & Assessment Service; c2015" (2018)[URL]
- Auffenberg GB, "Established medical therapy for benign prostatic hyperplasia", Urol Clin North Am, 36, pp.443~459 (2009)
- Nickel JC, "2010 Update : guidelines for the management of benign prostatic hyperplasia", Can Urol Assoc J, 4, pp.310~316 (2010)
- Masumori N, "Surgical procedures for benign prostatic hyperplasia : a nationwide survey in Japan", Int J Urol, 18, pp.166~170 (2011)
- Hueber PA, "Canadian trend in surgical management of benign prostatic hyperplasia and laser therapy from 2007-2008 to 2011-2012", Can Urol Assoc J, 7, pp.E582~6 (2013)
- Schroeck FR, "Population based trends in the surgical treatment of benign prostatic hyperplasia", J Urol, 188, pp.1837~1841 (2012)
- 이영주, "Nationwide incidence and treatment pattern of benign prostatic hyperplasia in Korea", Investigative and Clinical Urology, 57(6), pp.424~430 (2016), 대한비뇨의학회[DOI]
- Gratzke C, "EAU guidelines on the assessment of nonneurogenic male lower urinary tract symptoms including benign prostatic obstruction", Eur Urol, 67, pp.1099~1109 (2015)
- Rassweiler J, "Complications of transurethral resection of the prostate(TURP)--incidence, management, and prevention", Eur Urol, 50, pp.969~979 (2006)
- Seki N, "Evaluation of the learning curve for photoselective vaporization of the prostate over the course of 74 cases", J Endourol, 22, pp.1731~1735 (2008)
- Stone BV, "Safety and efficacy of GreenLight XPS laser vapoenucleation in prostates measuring over 150 mL", J Endourol, 30, pp.906~912 (2016)
- Horasanli K, "Photoselective potassium titanyl phosphate(KTP)laser vaporization versus transurethral resection of the prostate for prostates larger than 70 mL : a short-term prospective randomized trial", Urology, 71, pp.247~251 (2008)
- Elmansy H, "Holmium laser enucleation versus photoselective vaporization for prostatic adenoma greater than 60 ml : preliminary results of a prospective, randomized clinical trial", J Urol, 188, pp.216~221 (2012)
- Montorsi F, "Holmium laser enucleation versus transurethral resection of the prostate: results from a 2-center, prospective, randomized trial in patients with obstructive benign prostatic hyperplasia", J Urol, 172(5 Pt 1), pp.1926~1929 (2004)
- Gilling PJ, "Long-term results of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection of the prostate : results at 7 years", BJU Int, 109, pp.408~411 (2012)
- Ahyai SA, "Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement", Eur Urol, 58, pp.384~397 (2010)
- Kuntz RM, "Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100grams : 5-year follow-up results of a randomised clinical trial", Eur Urol, 53, pp.160~166 (2008)
- Brunckhorst O, "Evaluation of the learning curve for holmium laser enucleation of the prostate using multiple outcome measures", Urology, 86, pp.824~829 (2015)
- Elmansy HM, "Holmium laser enucleation of the prostate : long-term durability of clinical outcomes and complication rates during 10 years of followup", J Urol, 186, pp.1972~1976 (2011)
- Madersbacher S, "Reoperation, myocardial infarction and mortality after transurethral and open prostatectomy : a nation-wide, longterm analysis of 23, 123 cases", Eur Urol, 47, pp.499~504 (2005)
- Bozkurt A, "Prostatic urethral lift : a new minimally invasive treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia", Urol Int, 96, pp.202~206 (2016)
- Nunes RLV, "Contemporary surgical treatment of benign prostatic hyperplasia", Rev Assoc Med Bras(1992), 63, pp.711~716 (2017)